Session 3

EARLY INTERVENTION IN PV - AIMING FOR DISEASE MODIFICATION

CHAIRS: J.J Kiladjian & H. Gisslinger

10:00 - 10:30

Pre-clinical aspects

A. Mullally

10:30 - 11:00

IFN guidelines

T. Barbui

11:00 - 11:30

Practical considerations

M. Griesshammer

11:30 - 13:00

LUNCH BREAK

Session 4

Patient Cases

CHAIRS: V. Buxhofer-Ausch & A. Hatalová

13:00 - 13:20

Ropeg for low risk PV - Academic question or reality?

P. Schafhausen

13:20 - 13:40

Pre-treated PV

S. Papageorgiou

13:40 - 14:00

CHIP patient

M. Egyed

14:00 - 14:20

Switch patient case

T. Sliwa

14:20 - 14:40

Combination therapy

H. Gisslinger

14:40 - 15:00

Efficacy of interferon in PV - A matter of dose?

J. Göthert

15:00 - 15:30

COFFEE BREAK

Session 5

CML - SET THE SCENE

CHAIR: A. Burchert & J. Góra-Tybor

15:30 - 16:00

TKIs - A backbone with limitations

F. Stegelmann

16:00 - 16:30

IFN in CML - a critical review

A. Burchert